Back to Search
GERALD AHMANN, MD
Hematology & Oncology Physician
NPI: 1124073671Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD13148(OR)
Research & Publications (20)
Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.
PMID 18567838·Blood·2008
5-case
Effect of tissue shipping on plasma cell isolation, viability, and RNA integrity in the context of a centralized good laboratory practice-certified tissue banking facility.
PMID 18349285·Cancer Epidemiol Biomarkers Prev·2008
8-other
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
PMID 17692805·Cancer Cell·2007
8-other
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications.
PMID 16840723·Blood·2007
8-other
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.
PMID 17409404·Cancer Res·2007
3-trial
Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution.
PMID 17568814·Leukemia·2007
8-other
6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
PMID 16938573·Cancer Genet Cytogenet·2006
8-other
Clinical implication of centrosome amplification in plasma cell neoplasm.
PMID 16373658·Blood·2006
8-other
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma.
PMID 17024118·Leukemia·2006
8-other
Ploidy status rarely changes in myeloma patients at disease progression.
PMID 16111750·Leuk Res·2006
3-trial
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
PMID 16511510·Leukemia·2006
4-observational
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
PMID 15920009·Blood·2005
4-observational
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy.
PMID 15976175·Blood·2005
8-other
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma.
PMID 14726402·Blood·2004
3-trial
Assays for neoplastic cell enrichment in bone marrow samples.
PMID 12710218·Methods Mol Med·2003
6-review
Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.
PMID 12351413·Blood·2002
8-other
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.
PMID 11801310·Cancer Genet Cytogenet·2002
8-other
Genomic abnormalities in monoclonal gammopathy of undetermined significance.
PMID 12149226·Blood·2002
8-other
Systemic therapy of myeloma xenografts by an attenuated measles virus.
PMID 11567982·Blood·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2828 E BARNETT RD
MEDFORD, OR 97504 - Phone
- (541) 774-5853
Quick Facts
- NPI
- 1124073671
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile